STAT3 and hepatocellular carcinoma: Our previous studies have confirmed that blocking STAT3 signalling in HCC with STAT3 decoy‐oligodeoxynucleotide (‐ODN) could effectively inhibit the proliferation of HCC cells in vitro and in vivo [18].